BHVN
Price
$23.40
Change
+$1.98 (+9.24%)
Updated
Apr 24 closing price
Capitalization
2.39B
14 days until earnings call
FTRE
Price
$5.86
Change
+$0.54 (+10.15%)
Updated
Apr 24 closing price
Capitalization
528.57M
17 days until earnings call
Ad is loading...

BHVN vs FTRE

Header iconBHVN vs FTRE Comparison
Open Charts BHVN vs FTREBanner chart's image
Biohaven
Price$23.40
Change+$1.98 (+9.24%)
Volume$1.92M
Capitalization2.39B
Fortrea Holdings
Price$5.86
Change+$0.54 (+10.15%)
Volume$2.49M
Capitalization528.57M
BHVN vs FTRE Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. FTRE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Buy and FTRE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BHVN: $23.40 vs. FTRE: $5.86)
Brand notoriety: BHVN and FTRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 136% vs. FTRE: 94%
Market capitalization -- BHVN: $2.39B vs. FTRE: $528.57M
BHVN [@Biotechnology] is valued at $2.39B. FTRE’s [@Biotechnology] market capitalization is $528.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileFTRE’s FA Score has 1 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • FTRE’s FA Score: 1 green, 4 red.
According to our system of comparison, FTRE is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 4 TA indicator(s) are bullish while FTRE’s TA Score has 5 bullish TA indicator(s).

  • BHVN’s TA Score: 4 bullish, 4 bearish.
  • FTRE’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а +14.87% price change this week, while FTRE (@Biotechnology) price change was +10.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BHVN is expected to report earnings on Aug 04, 2025.

FTRE is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($2.39B) has a higher market cap than FTRE($529M). BHVN YTD gains are higher at: -37.349 vs. FTRE (-68.579). FTRE has higher annual earnings (EBITDA): -64.3M vs. BHVN (-877.26M). BHVN has more cash in the bank: 486M vs. FTRE (118M). BHVN has less debt than FTRE: BHVN (36.6M) vs FTRE (1.2B). FTRE has higher revenues than BHVN: FTRE (2.7B) vs BHVN (0).
BHVNFTREBHVN / FTRE
Capitalization2.39B529M451%
EBITDA-877.26M-64.3M1,364%
Gain YTD-37.349-68.57954%
P/E RatioN/AN/A-
Revenue02.7B-
Total Cash486M118M412%
Total Debt36.6M1.2B3%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHVNFTRE
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 9 days ago
68%
Declines
ODDS (%)
Bearish Trend 18 days ago
73%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
56%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFUEX26.320.54
+2.09%
DFA US Social Core Equity 2 Portfolio
NBPIX44.33N/A
N/A
Neuberger Berman Large Cap Value Instl
ADOCX17.29N/A
N/A
Alger Dynamic Opportunities C
DCUAX12.60N/A
N/A
DWS CROCI US A
RFISX16.15N/A
N/A
Ranger Small Cap Institutional

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with XENE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+9.24%
XENE - BHVN
50%
Loosely correlated
+1.62%
CGON - BHVN
49%
Loosely correlated
+3.81%
OCUL - BHVN
49%
Loosely correlated
+0.64%
RCKT - BHVN
48%
Loosely correlated
+4.06%
SYRE - BHVN
47%
Loosely correlated
+4.99%
More

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BHVN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BHVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+10.15%
BHVN - FTRE
45%
Loosely correlated
+9.24%
TECH - FTRE
41%
Loosely correlated
+1.24%
JAZZ - FTRE
40%
Loosely correlated
+4.60%
DNLI - FTRE
39%
Loosely correlated
+4.17%
XNCR - FTRE
37%
Loosely correlated
-0.28%
More